CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 8-K Event Exit or restructuring costs · Executive or director change
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise 10% owner acquired 1,648,289 shares (option exercise)
- 4 Option exercise Director acquired 1,648,289 shares (option exercise)
- 4 Option exercise Director acquired 350,853 shares (option exercise)
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Shareholder rights changed
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Exit or restructuring costs · Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 998,204 shares at an average $0.16 ($158,772)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K/A Event Delisting notice
- 8-K Event Material agreement · Agreement ended · Delisting notice · Executive or director change · Other events
- 8-K Event Other events
Page 32 of 45 · 895 filings